StockGuru Stocks to Watch for Wednesday, May 30, 2007 Featuring Andover Medical, and Genesis Technology

Andover Medical, Inc. (OTCBB: ADOV)Andover Medical, Inc. (OTCBB: ADOV) – Tuesday’s shares went up 3.85% to $0.54. 13,009 was the volume. Andover Medical announced on May 24th that the Company closed a $1.7 million follow-on private financing on May 3, 2007. Edwin Reilly, Chief Executive Officer of Andover Medical, Inc. said, “This additional round of financing of $1.7 Million was made available to investors after closing our recently announced $5.6 Million equity financing in March of this year. We have demonstrated a continued ability to access the capital markets through strong investor demand for our newly issued securities. This indicates that our investors have confidence in our business strategy and share our vision for the development of Andover’s unified network of DME providers. Now as a funded company, Andover is more favorably positioned to execute as we build-out and realize the synergies from the creation of this national network.”Andover Medical is building a single source provider of orthopedic, podiatric and urological durable medical equipment (”DME”) and incontinence treatment solutions. The Company intends to establish a nationwide subsidiary network and plans to offer practitioners the largest selection of competitively priced brand-name durable medical equipment, and urodynamic diagnostic and treatment products. Andover Medical is seeking to take advantage of projected growth and evolving economies of scale arising from consolidation in the procedure specific durable medical equipment (DME) and services segments of the orthopedic, podiatric, and urological physician care markets in the United States. By establishing a nationwide subsidiary network, AMI plans to offer physicians the largest selection of competitively priced brand-name DME, and urodynamic diagnostic and treatment products. These products include, devices to aid the recovery from Anterior Cruciate Ligament (ACL) surgery, knee replacements, and hip replacements.

Genesis Technology Group, Inc. (OTCBB: GTEC)

Genesis Technology Group, Inc. (OTCBB: GTEC) – Tuesday’s shares increased 11.11% to $0.15. 228,794 shares were traded. Genesis Technology Group announced on May 17th it has signed a leading Chinese pharmaceutical company as the sixth member of its private-to-public partnering program. Based on information provided by the Chinese company, fiscal 2006 revenues topped $92 million and net profits exceeded 16%. “Our newest partner company is decidedly our largest to date,” remarked Dr. Shaohua Tan, Genesis Director in Beijing. “Our U.S. executive team soon will assemble in China to conduct discussions on how to best utilize this well-established pharmaceutical company in our capital and growth program.

Genesis Technology Group, Inc. attempts to create value by partnering with Chinese companies deserving of global support from Western investors and funding sources. They have created a profit center by enhancing Chinese companies in a wide range of sectors, creating so-coined “partner companies”. Genesis makes a long-term commitment with management consultation, board of directors’ composition, creation and implementation of promising business models, which include expansion of markets in China and abroad. To help drive the success and profitability of these operations, Genesis provides resources and proficiency to maximize partners’ leadership potential first in China and attempts to increase high-margin, predictable earnings through organic growth and judicious acquisitions.

We Invite you to Visit the All New StockGuru Blog!

Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks.

Click HERE to visit the Blog, or go to:

http://stockguru.com/blog/

StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (469) 252-3030. Web: StockGuru.com. Email: Publisher@stockguru.com. ADOV Disclosure: Pentony Enterprises LLC is compensated for profile coverage of many publicly traded companies. Compensation is clearly shown in detail when that is the case. GTEC Disclosure: Pentony Enterprises LLC has been compensated $3,600 and 265,000 restricted shares directly from the company for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.